POSITRON EMISSION TOMOGRAPHY SCANNERS MARKET ANALYSIS

Positron Emission Tomography (PET) Scanners Market, By Product Type (Full Ring PET Scanner, Partial Ring PET Scanner), By Application (Oncology, Cardiology, Neurology, Others), By Detector Type (Bismuth Germanium Oxide, Lutetium Oxyorthosilicate, Gadolinium Oxyorthosilicate, Lutetium Fine Silicate, Lutetium Yttrium Orthosilicate), By End User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In November 2023, Siemens Healthineers,Healthcare companyhas announced that the Biograph Vision.X, a positron emission tomography/computed tomography (PET/CT) scanner, has received clearance from the Food and Drug Administration (FDA). This next-generation system features a time of flight (TOF) of 178 picoseconds (ps), making it the fastest in the industry.
In August 2022, Positron Corporation, a company specializing in nuclear medicine PET imaging devices and clinical services, acquired its first PET-CT system from its partner Neusoft Medical Systems. The "Affinity PET-CT" system is currently en route from China to its validation partner in the United States.
In July 2022, Radialis Inc.,aninnovative medtech company received approval to market its Radialis PET Imager in the United States. This organ-targeted positron emission tomography (PET) system boasts advanced sensitivity to radiotracers, allowing it to produce high-resolution functional images and enhance the insights gained from molecular imaging.